Introduction: Insomnia, also known as sleeplessness, is a sleeping condition where people have difficulty sleeping. It may be difficult for them to fall asleep or remain asleep as long as needed. Daytime sleepiness, low energy, irritability, and a depressed mood are usually accompanied by insomnia. Some studies showed that COVID-19 patients can suffer from insomnia during their infection period and they attributed it to the stress and depression experienced by the patients during the disease.

Materials and methods: It is cross-sectional study that includes 1215 participants from 15 counties. The inclusion criteria were a recovered patient from COVID-19 with no history of psychological disorders of depression, anxiety, stress or insomnia or any sleep disorder. Athena’s Insomnia Scale was used in diagnosis of Insomnia with score of ≥ 6. 

Results: The insomnia score of the patients was with mean and standard deviation of 7.04 ± 4.9, although 77.6% of them were with score ≥ 6 as they have insomnia, while 22.4% have not. There was a significant difference between the severity of the symptoms and the insomnia status with P-value of 0.047. About one third of them visited a doctor because of their sleep quality and 29% of them took medications to help them to take enough sleep.

Conclusion: Insomnia can be common after COVID-19 infection and it can sever in many people and may need treatment and follow-up. People from countries that have bad health care and the elderlies have an increased risk of having insomnia after COVID-19 infection.